Table 1.
Group | sIgE (ng/mL) | IFN-γ (mg/mL) | IL-4 (pg/mL) |
---|---|---|---|
Control | 72.65±9.17 | 0.59±0.06 | 10.74±3.05 |
Model | 124.92±15.56# | 0.29±0.07△ | 16.04±3.81∗ |
Budesonide | 126.34±13.20# | 0.27±0.05△ | 16.75±5.01∗ |
Sham | 127.06±14.20# | 0.26±0.06△ | 16.90±2.75∗ |
C1 | 129.20±11.12# | 0.28±0.06△ | 17.32±3.05∗ |
C2 | 127.49±12.51# | 0.25±0.05△ | 17.18±2.98∗ |
Note: serum levels were measured as described under Methods. ∗P < 0.01 versus the control group; △P < 0.01 versus the control group; #P < 0.01 versus the control group.